Viewing StudyNCT06406816



Ignite Creation Date: 2024-05-11 @ 8:30 AM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06406816
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-09
First Post: 2024-05-06

Brief Title: Neoantigen Vaccine Plus Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma After Radical Resection
Sponsor: Yongyi Zeng
Organization: Meng Chao Hepatobiliary Hospital of Fujian Medical University

Organization Data

Organization: Meng Chao Hepatobiliary Hospital of Fujian Medical University
Class: OTHER
Study ID: 2024_033_01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Yongyi Zeng
Lead Sponsor Class: OTHER
Responsible Party: Yongyi Zeng
Responsible Party Title: Director
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation: Meng Chao Hepatobiliary Hospital of Fujian Medical University
Old Name: None
Old Organization: None

Collaborators